SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines

被引：0
作者：
Giovanni Salvatori
Laura Luberto
Mariano Maffei
Luigi Aurisicchio
Giuseppe Roscilli
Fabio Palombo
Emanuele Marra
机构：
[1] Takis s.r.l,
[2] Evvivax s.r.l,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
SARS-CoV-2; SPIKE protein; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
COVID-19 has rapidly spread all over the world, progressing into a pandemic. This situation has urgently impelled many companies and public research institutes to concentrate their efforts on research for effective therapeutics. Here, we outline the strategies and targets currently adopted in developing a vaccine against SARS-CoV-2. Based on previous evidence and experience with SARS and MERS, the primary focus has been the Spike protein, considered as the ideal target for COVID-19 immunotherapies.
引用
收藏
相关论文
共 55 条
[1]  
Buchholz UJ(2004)Contributions of the structural proteins of severe respiratory syndrome coronavirus to protective immunity Proc Natl Acad Sci USA 26 9804-9809
[2]  
Bukreyev A(2004)An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Nat Med 10 871-875
[3]  
Yang L(2015)Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus Proc Natl Acad Sci USA 112 10473-10478
[4]  
Lamirande EW(2020)Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein Cell 180 1-12
[5]  
Murphy BR(2020)Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Cell Mol Immunol 22 72-73
[6]  
Subbarao K(2020)Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect 11 82-214
[7]  
Traggiai E(2014)Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus Virol J. 7 4-204
[8]  
Becker S(2012)Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus PLoS ONE 451 208-undefined
[9]  
Subbarao K(2014)Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins Biochem Biophys Res Commun 33 201-undefined
[10]  
Kolesnikova L(2018)Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine Virol Sin. undefined undefined-undefined
123456